We’re proud to announce AJ Keefe as our last HDBuzz Prize winner of 2024! Our cells are an intricate choreography between ...
Ed is a neurologist at the National Hospital for Neurology and Neurosurgery, London, UK, and a Professor of Neurology at University College London where he is Associate Director of the Huntington’s ...
Michael is a consultant neurologist in the department of neurology at the University of Ulm in Germany, and scientific projects manager for the European Huntington’s disease network. Michael trained ...
A well-studied, widely used class of drugs for heart health may have benefits for Huntington’s disease. A new paper ...
Vico Therapeutics recently presented at several conferences to share an interim update on their Phase 1/2a clinical trial testing their drug called VO659, which targets the repeating C-A-Gs in people ...
AJ is an Instructor of Cell Biology at Columbia Basin College in Pasco, Washington. During his undergraduate studies at Western Washington University, AJ worked on HD in Dr. Jeff Carroll's lab. AJ ...
On December 10, 2024 we received a regulatory update from uniQure about their drug, AMT-130, that they’re advancing through the clinic for Huntington’s disease (HD). On the call, uniQure announced ...
In plain language. Written by scientists. For the global HD community.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback